Vaccinex implements 1-for-15 reverse stock split effective Sept 25, 2023

VACCINEX, INC.

Reverse stock split at 1-for-15 ratio, effective 5:00 p.m. ET on September 25, 2023.
Objective to regain compliance with Nasdaq $1.00 minimum bid price by October 9, 2023.
Stock to trade on Nasdaq under symbol VCNX on split-adjusted basis from September 26, 2023.
Fractional shares resulting from the split will be rounded up to the nearest whole share.
No change to authorized shares or par value; CUSIP changes to 918640202.

item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

VACCINEX, INC.: Filing of Certificate of Amendment to effect a 1-for-15 reverse stock split (effective 2023-09-25).

Change: charter amendment
Effective: 2023-09-25

Exact text from the filing

On September 22, 2023, Vaccinex, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, with the Delaware Secretary of State to implement a reverse stock split of the Company’s issued shares of common stock at a ratio of 1-for-15, effective at 5:00 p.m. Eastern Time on September 25, 2023 (the “Reverse Stock Split”), previously approved by the Company’s Board of Directors.

View on SEC.gov

Browse all governance changes →

VACCINEX, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-240553

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.